KLRD1 and neoplasm: Previously, Gross et al. demonstrated that an increased expression density of CD94/NKG2C and CD56 initiates the NK cells capacity to kill membrane Hsp70-positive tumor cells (39, 40) and thereby acts as a surrogate marker for Hsp70-reactivity.